Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Puma Biotechnology Inc PBYI

Healthcare Biotechnology
Puma Biotechnology, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of products to enhance cancer care. The Company's lead product is NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Neratinib is a potent irreversible tyrosine kinase inhibitor (TKI) that blocks signal transduction through the epidermal... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PBYI)

Puma Biotechnology Announces Initiation of ALISCA(TM)-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Business Wire 2 days ago

Puma Biotechnology Reports Third Quarter 2024 Financial Results

Business Wire November 7, 2024

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire November 5, 2024

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

Business Wire October 24, 2024

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Business Wire September 3, 2024

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire August 6, 2024

Puma Biotechnology Reports Second Quarter Financial Results

Business Wire August 1, 2024

Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results

Business Wire July 18, 2024

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Business Wire July 2, 2024
View More News ››

Opinion & Analysis (NDAQ:PBYI)

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales

Streetwise Reports August 14, 2019

Use stock volatility to invest in innovative oncology companies: JMP Security's Michael King Jr.

Gail Dutton October 15, 2015

Small-Cap Growth ETFs Restore Leadership Role

Benzinga.com  March 19, 2015

Meet The 5 Companies Loving Obamacare

Benzinga.com  November 4, 2014

Earnings Beats Drive ETFs; LinkedIn Boosts Social Media ETF

Benzinga.com  July 24, 2014
View More Opinion ››

Bullboard Posts (NDAQ:PBYI)

PBYI ....is that a "drumroll" I'm hearing ???

Now $4.21....and heading North....break $4.25 and it just might catch.  Cheers !
Iseneschal - November 8, 2021

PBYI ...... Thru DTL ....on watch

Start the drumroll  Cheers !
Iseneschal - November 5, 2021

PBYI ....opportunity is a knockin....getting my B oda ready

just sayin......cheap paper makes the world go around !!!
Iseneschal - November 5, 2021

PBYI ....needs a break of $4.23 on this swing

Never know.... Cheers 1
Iseneschal - November 5, 2021

PBYI ...... Come on down.....

You're the next contestant on the Price is Right... LoL Beats Vegas by a mile !!!
Iseneschal - November 5, 2021

PBYI ..... dang....I was posting on AMPG's board

I was a buyer sub $4 and just above...scalped it for about 20 cents a share Hold some and waiting for a possible "Gap Fill"......
Iseneschal - November 5, 2021
View more Bullboard ››

TAG Oil Ltd.

TAG Oil Ltd.

TAG Oil Ltd. is an international oil and gas exploration company with a focus on operations and opportunities in the Middle ...
View More »